Treatment of Hand-Foot-Mouth Disease in Adults
Hand-foot-mouth disease (HFMD) in adults should be managed primarily with supportive care, but intravenous immunoglobulin (IVIG) should be strongly considered for severe cases with neurological complications, and off-label valacyclovir may provide symptomatic benefit in uncomplicated cases.
Approach to Management
Uncomplicated Cases (Majority)
Most adult HFMD cases are self-limited and resolve within 7-10 days without sequelae 1. Treatment focuses on:
- Symptomatic relief with analgesics for painful oral lesions and fever
- Isolation to prevent transmission 2
- Outpatient management is appropriate for mild cases 2
Consider off-label valacyclovir for symptomatic improvement. While the mechanism is unclear (Coxsackievirus lacks herpesvirus thymidine kinase), case reports demonstrate dramatic improvement within 10-48 hours 3. A 2026 case showed complete resolution within 48 hours in a 39-year-old female 3, and earlier reports from 1996 showed symptomatic relief and defervescence within 24 hours with oral acyclovir 4. The proposed mechanism may involve enhancement of the patient's own interferon response 4.
Severe Cases with Neurological Complications
Adults can develop serious complications including encephalomyelitis, meningitis, myocarditis, and brainstem involvement 5, 6. These presentations are rarer but more severe than in children.
Recognition of Severe Disease
Be alert for these warning signs that indicate potential deterioration 2:
- Persistent high fever
- Altered consciousness, ptosis, limb weakness 5
- Worsening respiratory rate/rhythm
- Circulatory dysfunction
- Elevated peripheral WBC, blood glucose, or lactic acid
Treatment of Severe Cases
Administer IVIG promptly for confirmed neurological involvement. A 2025 case report demonstrated that a single dose of IVIG in a 21-year-old woman with enterovirus 71-induced encephalomyelitis resulted in full recovery and helped reduce fever, skin lesions, and recovery time 5. IVIG is recommended by several national and international guideline committees for severe/complicated HFMD 1.
Diagnostic Confirmation
For suspected severe cases, obtain:
- Cerebrospinal fluid analysis with RT-PCR for enterovirus
- Brain and spinal cord MRI to confirm CNS involvement 5
- Throat, skin lesion, and anal swabs for viral identification 5
Clinical Pearls
History of contact with HFMD patients is crucial for diagnosis in adults, as the presentation may be atypical 5, 7. Adults can present with generalized vesiculopapular eruptions involving groin, trunk, and extremities beyond the classic hand-foot-mouth distribution 7.
Enterovirus 71 causes more severe disease than Coxsackievirus A16 and has higher complication rates 1. Adults over 20 years and immunocompromised individuals are at increased risk 8.
Common Pitfalls
- Misdiagnosis in adults: HFMD is often not considered in the differential for adult vesiculopapular eruptions, leading to unnecessary broad-spectrum antibiotics and invasive testing 7
- Missing atypical presentations: Lesions may be subtle or involve unusual distributions in adults 5
- Delayed recognition of neurological complications: Brainstem encephalitis can present insidiously with autonomic dysfunction, myoclonus, and cranial neuropathies 8
No specific antiviral agents are currently FDA-approved for HFMD, though ribavirin, suramin, and other agents are under investigation 1.